Kuwait Biobank Market Size & Outlook, 2026-2033

The biobank market in Kuwait is expected to reach a projected revenue of US$ 109.0 million by 2033. A compound annual growth rate of 5.1% is expected of Kuwait biobank market from 2026 to 2033.
Revenue, 2025 (US$M)
$73.9
Forecast, 2033 (US$M)
$109.0
CAGR, 2026 - 2033
5.1%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait biobank market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait biobank market highlights

  • The Kuwait biobank market generated a revenue of USD 73.9 million in 2025 and is expected to reach USD 109.0 million by 2033.
  • The Kuwait market is expected to grow at a CAGR of 5.1% from 2026 to 2033.
  • In terms of segment, services was the largest revenue generating product & services in 2025.
  • Services is the most lucrative product & services segment registering the fastest growth during the forecast period.


Biobank market data book summary

Market revenue in 2025USD 73.9 million
Market revenue in 2033USD 109.0 million
Growth rate5.1% (CAGR from 2026 to 2033)
Largest segmentServices
Fastest growing segmentServices
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationProduct, Services
Key market players worldwideThermo Fisher Scientific Inc, Merck KGaA, Qiagen NV, Booz Allen Hamilton Holding Corp Class A, Tecan Group AG, Danaher Corp, Becton Dickinson & Co, Taylor-Wharton, Charles River Laboratories International Inc, Lonza Group Ltd, STEMCELL Technologies, PromoCell GmbH


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.1% of the global biobank market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Middle East & Africa, Saudi Arabia biobank market is projected to lead the regional market in terms of revenue in 2033.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 444.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biobank Market Companies

Name Profile # Employees HQ Website
Booz Allen Hamilton Holding Corp Class A View profile 34200 8283 Greensboro Drive, Hamilton Building, McLean, VA, United States, 22102 https://www.boozallen.com
STEMCELL Technologies View profile 501-1000 Vancouver, British Columbia, Canada, North America https://www.stemcell.com
Taylor-Wharton View profile 251-500 Baytown, Texas, United States, North America https://twcryo.com
PromoCell GmbH View profile 51-100 Heidelberg, Baden-Wurttemberg, Germany, Europe http://www.promocell.com/
Tecan Group AG View profile 3591 Seestrasse 103, Mannedorf, Switzerland, 8708 https://www.tecan.com
Charles River Laboratories International Inc View profile 21400 251 Ballardvale Street, Wilmington, MA, United States, 01887 https://www.criver.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Kuwait biobank market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biobank market will help companies and investors design strategic landscapes.


Services was the largest segment with a revenue share of 90.12% in 2025. Horizon Databook has segmented the Kuwait biobank market based on product, services covering the revenue growth of each sub-segment from 2021 to 2033.


Kuwait ranks 46th among the 51 high-income group economies and ranks 10th among the 19 economies in Northern Africa and Western Asia. The country is also a part of the Gulf Cooperation Council (GCC) and presents many opportunities for investments in the healthcare industry. 

In addition, the country’s National Development Plan of USD 104 billion aims for major upgrades to Kuwait’s healthcare infrastructure and facilities. 

The country is also home to the National Dasman Diabetes Biobank (NDDB), which offers repository services for supporting research projects related to diabetes. Such institutions are expected to increase awareness about biobanking and its applications in the country. 

Reasons to subscribe to Kuwait biobank market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Kuwait biobank market databook

  • Our clientele includes a mix of biobank market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait biobank market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait biobank market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Kuwait biobank market size, by product & services, 2021-2033 (US$M)

Kuwait Biobank Market Outlook Share, 2025 & 2033 (US$M)

Kuwait biobank market size, by product & services, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online